Liu Hua
Lanzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
Journal: BMC pulmonary medicine
Published: July 24, 2018
Increased stathmin in serum as a potential tumor marker for lung adenocarcinoma.
Journal: Japanese journal of clinical oncology
Published: May 26, 2017
Increased level of annexin A1 in bronchoalveolar lavage fluid as a potential diagnostic indicator for lung cancer.
Journal: The International journal of biological markers
Published: November 02, 2016
Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies.
Journal: Oncotarget
Published: August 23, 2016
Increased stathmin in serum as a potential tumor marker for lung adenocarcinoma.
Journal: Japanese journal of clinical oncology
Published: August 19, 2016
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developments.
Journal: Journal of translational medicine
Published: May 02, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026